Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Aug 14, 2025

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has...